Cogent Biosciences (COGT) Non Operating Income (2017 - 2026)

Cogent Biosciences' Non Operating Income history runs 10 years deep, the most recent figure standing at -$140000.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 104.75% year-over-year to -$140000.0; the TTM figure through Mar 2026 stood at -$155000.0 (down 100.82% YoY), while the FY2025 annual figure was -$20000.0, down 100.1% from the prior year.
• Non Operating Income was -$140000.0 for Q1 2026 at Cogent Biosciences, down from -$6000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $5.8 million in Q4 2024 to a low of -$10.9 million in Q4 2023.
• Historically, Non Operating Income has averaged $1.1 million across 5 years, with a median of $784000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income slumped 793.13% in 2023, then surged 294800.0% in 2025.
• A 5-year view of Non Operating Income shows it stood at -$1.2 million in 2022, then slumped by 793.13% to -$10.9 million in 2023, then surged by 153.21% to $5.8 million in 2024, then plunged by 100.1% to -$6000.0 in 2025, then slumped by 2233.33% to -$140000.0 in 2026.
• The last three Non Operating Income figures came in at -$140000.0 (Q1 2026), -$6000.0 (Q4 2025), and -$3000.0 (Q3 2025), per Business Quant data.